NIFK, a Potential Prognostic and Immunological Biomarker in Pan-- Cancer Analysis, Significantly Regulates Proliferation and Metastasis of Colorectal Cancer.
Zhuoyuan LiShangbo ZhouTing BinYuntao ShiLeli ZengBo LiJia LiYulong HeChanghua ZhangPublished in: Recent patents on anti-cancer drug discovery (2024)
The results of this study demonstrated that NIFK, as a member of the pan-cancer genes, will serve as a biomarker and a potential therapeutic target for a range of cancer types, providing new insight into precision medicine.